[关键词]
[摘要]
视网膜色素变性(retinitis pigmentosa，RP)也称为色素性视网膜炎。RP是由于视网膜色素上皮细胞功能逐渐丧失及光感受器进行性凋亡从而导致不可逆的视力损伤的一组遗传性眼病。因其表型和遗传均具有异质性，发病机制复杂，目前尚无单一有效的治疗方法。本文报告近年来RP在诊疗方面的进展。
[Key word]
[Abstract]
Retinitis pigmentosa(RP)was known as pigmentation retinitis even. RP is a group of hereditary eye diseases that cause irreversible visual impairment due to progressive loss of function of retinal pigment epithelial cells and progressive apoptosis of photoreceptors. Because of its heterogeneity in phenotype and heredity and complex pathogenesis, there is currently no single effective treatment. This article mainly elaborates on the progress in the treatment of retinitis pigmentosa in recent years.
[中图分类号]
[基金项目]
国家自然科学基金资助项目(No.81770948); 福建省科技创新领军人才基金资助项目(No.2016B011)
